stars 1 stars 2 stars 3

ExoAtlet is a Russian company engaged in development and production of exoskeletons, creation of the efficient rehabilitation methods for the patients with consequences of spinal injuries, suffered stroke, ICP, multiocular sclerosis and other nosology. The key task for the exoskeleton is to ensure efficient rehabilitation of the patients with locomotor disorders of lower limb and in perspective - restoration of the patient's motor function. ExoSkeloton is a young and dynamically developing innovation start-up launched in 2013. In June 2014, ExoSkeleton won the Russian national start-ups contest Startup Village and became a resident of the Skolkovo information technology cluster. For 6 years, several exoskeleton modifications were created and mass exoskeleton production started. The Neuronet task force of the National Technology Initiative supported the project of creation of children exoskeleton ExoAtlet Bambini. "ExoAtlet" company is a portfolio company of RVC Biofund.

ExoAtlet Questions

The ExoAtlet annual revenue was $6.3 million in 2026.

ExoAtlet is based in Esch sur Alzette, Luxembourg.

The NAICS codes for ExoAtlet are [33, 339].

The SIC codes for ExoAtlet are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users